Literature DB >> 21584063

Obsessive compulsive neurosis : clomipramine, prolactin and therapeutic response.

J Ananth1, A Kaur, R Poland, M Wohl.   

Abstract

This study was designed to assess the relationship between psychopathology and serotonin generated prolactin response to clomipramine and to assess the relationship between improvement in psychopathology and prolactin levels. The experimental sample consisted of 15 patients in the drug and 12 patients in the placebo groups. Blood samples for prolactin levels were drawn at baseline, and at the end of 4,8, and 12 weeks. There were statistically significant differences in prolactin increase between the drug and the placebo groups at 4 but not at 12 weeks following treatment. When the four least improved and a similar number of the most improved patients were compared, the least improved patients had the most increase in prolactin and the most improved had the least increase.

Entities:  

Keywords:  Clomipramine; obsessive compulsive neurosis; prolactin response to clomipramine

Year:  1997        PMID: 21584063      PMCID: PMC2967101     

Source DB:  PubMed          Journal:  Indian J Psychiatry        ISSN: 0019-5545            Impact factor:   1.759


  29 in total

1.  Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers.

Authors:  E Hollander; C M DeCaria; A Nitescu; R Gully; R F Suckow; T B Cooper; J M Gorman; D F Klein; M R Liebowitz
Journal:  Arch Gen Psychiatry       Date:  1992-01

2.  Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.

Authors:  T A Pigott; M T Pato; S E Bernstein; G N Grover; J L Hill; T J Tolliver; D L Murphy
Journal:  Arch Gen Psychiatry       Date:  1990-10

3.  Prolactin in childhood obsessive-compulsive disorder: clinical correlates and response to clomipramine.

Authors:  G L Hanna; J T McCracken; D P Cantwell
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1991-03       Impact factor: 8.829

4.  Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder.

Authors:  T A Pigott; J Zohar; J L Hill; S E Bernstein; G N Grover; R C Zohar-Kadouch; D L Murphy
Journal:  Biol Psychiatry       Date:  1991-03-01       Impact factor: 13.382

Review 5.  Serotonin receptor specificity in anxiety disorders.

Authors:  I Lucki
Journal:  J Clin Psychiatry       Date:  1996       Impact factor: 4.384

6.  A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group.

Authors:  S A Montgomery; A McIntyre; M Osterheider; P Sarteschi; W Zitterl; J Zohar; M Birkett; A J Wood
Journal:  Eur Neuropsychopharmacol       Date:  1993-06       Impact factor: 4.600

7.  Molecular cloning and functional expression of 5-HT1E-like rat and human 5-hydroxytryptamine receptor genes.

Authors:  T W Lovenberg; M G Erlander; B M Baron; M Racke; A L Slone; B W Siegel; C M Craft; J E Burns; P E Danielson; J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

Review 8.  Sertraline in the treatment of obsessive compulsive disorder: two double-blind, placebo-controlled studies.

Authors:  G Chouinard
Journal:  Int Clin Psychopharmacol       Date:  1992-10       Impact factor: 1.659

9.  A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPP.

Authors:  T A Pigott; J L Hill; T A Grady; F L'Heureux; S Bernstein; C S Rubenstein; D L Murphy
Journal:  Biol Psychiatry       Date:  1993-01-01       Impact factor: 13.382

10.  Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.

Authors:  C P Freeman; M R Trimble; J F Deakin; T M Stokes; J J Ashford
Journal:  J Clin Psychiatry       Date:  1994-07       Impact factor: 4.384

View more
  1 in total

1.  Research on antidepressants in India.

Authors:  Ajit Avasthi; Sandeep Grover; Munish Aggarwal
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.